BridgeMD
New treatment option for Medullary Thyroid Carcinoma
Official title Research on the Application of 68Ga-DOTA-CCK-FS PET/CT in MTC
ClinicalTrials.gov ID: NCT07138716
What this study is testing
- What it's testing
- This study explores the clinical application of 68Ga-DOTA-CCK-FS PET/CT in detecting cholecystokinin-2 receptor (CCK-2R)-positive tumors, particularly medullary thyroid cancer (MTC) and other malignancies. Led by Prof.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults. Healthy volunteers may be eligible.
You may be able to join if
- Age not limited (male or female).
- Diagnosis:Confirmed or suspected medullary thyroid carcinoma (MTC) based on: Fine-needle aspiration (FNA) cytology/histopathology, or Elevated serum...
- Performance Status: Life expectancy ≥12 weeks.
- Contraception: Willingness to use effective birth control (if applicable).
- Consent: Signed informed consent and compliance with follow-up.
You likely can't join if
- Severe hepatic/renal dysfunction (e.g., ALT/AST \>3×ULN, Cr \>2.0 mg/dL).
- Pregnancy/lactation or planned pregnancy during the study.
- Inability to lie still for PET/CT (e.g., severe claustrophobia).
- Concurrent conditions compromising study safety (investigator's judgment). \ Note: CCK-2R positivity may be confirmed via prior immunohistochemistry...
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.